The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma
Authors:
Open Access
- 5 July 2023
- journal article
- research article
- Published by Springer Nature in Discover Oncology
- Vol. 14 (1) , 1-17
Abstract
Tumor-infiltrating immune cells and fibroblasts are significant components of the tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC), and they participate in tumor progression as closely as tumor cells. However, the relationship between the features of the TME and patient outcomes and the interactions among TME components are still unclear. In this study, we evaluated the PDAC TME in terms of the quantity and location of cluster of differentiation (CD)4+ T cells, CD8+ T cells, macrophages, stromal maturity, and tumor-stroma ratio (TSR), as evaluated by immunohistochemical staining of serial whole-tissue sections from 116 patients with PDAC. The density of T cells and macrophages (mainly activated macrophages) was significantly higher at the invasive margins (IMs) than at the tumor center (TC). CD4+ T cells were significantly association with all the other tumor-associated immune cells (TAIs) including CD8, CD68 and CD206 positive cells. Tumors of the non-mature (intermediate and immature) stroma type harbored significantly more CD8+ T cells at the IMs and more CD68+ macrophages at the IMs and the TC. The density of CD4+, CD8+, and CD206+ cells at the TC; CD206+ cells at the IMs; and tumor-node-metastasis (TNM) staging were independent risk factors for patient outcomes, and the c-index of the risk nomogram for predicting the survival probability based on the TME features and TNM staging was 0.772 (95% confidence interval: 0.713–0.832). PDAC harbored a significantly immunosuppressive TME, of which the IMs were the hot zones for TAIs, while cells at the TC were more predictive of prognosis. Our results indicated that the model based on the features of the TME and TNM staging could predict patient outcomes.Keywords
Funding Information
- the Joint Funds for the innovation of science and Technology, Fujian province (2021Y9145)
- Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases (FKLTR-202101)
- the 2020 Fujian Provincial Health Science and Technology Project for Youth Research Project (2020QNA041)
- the Scientific Research Project of National Key Clinical Specialty Construction Project (2022YBL-ZD-05)
This publication has 48 references indexed in Scilit:
- Cancer‐associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinomaCancer Medicine, 2017
- Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic CancerClinical Cancer Research, 2015
- Inflammatory features of pancreatic cancer highlighted by monocytes/macrophages and CD4+ T cells with clinical impactCancer Science, 2015
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Annals of Oncology, 2014
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal AdenocarcinomaCancer Cell, 2014
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced SurvivalCancer Cell, 2014
- Tumor‐associated macrophages exhibit pro‐ and anti‐inflammatory properties by which they impact on pancreatic tumorigenesisInternational Journal of Cancer, 2014
- Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal AdenocarcinomaGastroenterology, 2013
- CD8+ Tumor-Infiltrating Lymphocytes Together with CD4+ Tumor-Infiltrating Lymphocytes and Dendritic Cells Improve the Prognosis of Patients with Pancreatic AdenocarcinomaPancreas, 2004
- Das TNM-System zur Klassifikation von TumorkrankheitenJournal of Molecular Medicine, 1968